These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7946573)

  • 21. Erlotinib and pancreatic adenocarcinoma: uncertainty and hope.
    Zoras O; Batsis C
    Ann Surg Oncol; 2011 Dec; 18 Suppl 3():S246-7. PubMed ID: 21630121
    [No Abstract]   [Full Text] [Related]  

  • 22. A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma.
    Eatock MM; Anthony DA; El-Abassi M; Wilson P; Paul J; Smith M; Soukop M; Evans TR
    Br J Cancer; 2000 Jun; 82(12):1925-31. PubMed ID: 10864199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Von Hoff DD; Goldstein D; Renschler MF
    N Engl J Med; 2014 Jan; 370(5):479-80. PubMed ID: 24476438
    [No Abstract]   [Full Text] [Related]  

  • 24. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Saltz LB; Bach PB
    N Engl J Med; 2014 Jan; 370(5):478. PubMed ID: 24476439
    [No Abstract]   [Full Text] [Related]  

  • 25. Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.
    Sahoo RK; Kumar L
    N Engl J Med; 2014 Jan; 370(5):478-9. PubMed ID: 24476440
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer.
    Porta C; Nastasi G; Spaghi A; Moroni M
    Lancet; 1990 Dec; 336(8728):1454-5. PubMed ID: 1978920
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in chemotherapy for pancreatic adenocarcinoma].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of epirubicin, etoposide and cisplatin in gastric cancer. A phase II study.
    Barone C; Cassano A; Astone A; Ricevuto E; Fontana T; Noviello MR; Garufi C; Pacelli F; Grieco A
    Oncology; 1991; 48(5):353-5. PubMed ID: 1745479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
    Iveson T; Donehower RC; Davidenko I; Tjulandin S; Deptala A; Harrison M; Nirni S; Lakshmaiah K; Thomas A; Jiang Y; Zhu M; Tang R; Anderson A; Dubey S; Oliner KS; Loh E
    Lancet Oncol; 2014 Aug; 15(9):1007-18. PubMed ID: 24965569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer.
    González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacon I; Garrido P; Colmenarejo A
    Eur J Cancer; 1994; 30A(11):1733-4. PubMed ID: 7833158
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical efficacy of the combination chemotherapy of high-dose epirubicin in non-small cell lung cancer].
    Xiao QM; Zhang WD; Zhou JH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):397-8. PubMed ID: 12536753
    [No Abstract]   [Full Text] [Related]  

  • 32. Leuprolide and tamoxifen in the treatment of pancreatic cancer. A phase II study.
    Zaniboni A; Meriggi F; Arcangeli G; Alghisi A; Huscher C; Marini G
    Eur J Cancer; 1994; 30A(1):128. PubMed ID: 8142155
    [No Abstract]   [Full Text] [Related]  

  • 33. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma.
    Highley MS; Parnis FX; Trotter GA; Houston SJ; Penson RT; Harper PG; Mason RC
    Br J Surg; 1994 Dec; 81(12):1763-5. PubMed ID: 7530150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined epirubicin, 5-fluorouracil and folinic acid vs no treatment for patients with advanced pancreatic cancer: a prospective comparative study.
    Tsavaris N; Tentas K; Tzivras M; Kosmas C; Kalachanis N; Katsikas M; Dimitrakopoulos A; Papastratis G; Macheras A; Karatzas G; Sechas M
    J Chemother; 1998 Aug; 10(4):331-7. PubMed ID: 9720474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 36. Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer.
    Sirohi B; Barreto SG; Singh A; Batra S; Mittra A; Rastogia S; Ramadwar M; Shetty N; Goel M; Shrikhande SV
    J Cancer Res Ther; 2014; 10(4):866-70. PubMed ID: 25579520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of epirubicin in combination with weekly docetaxel for patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based chemotherapy.
    Lin CM; Chen CH; Chang JW; Tsao TC
    Am J Clin Oncol; 2009 Apr; 32(2):169-73. PubMed ID: 19307958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial.
    Eltweri AM; Thomas AL; Chung WY; Morgan B; Thompson J; Dennison AR; Bowrey DJ
    Anticancer Res; 2019 Feb; 39(2):853-861. PubMed ID: 30711967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epirubicin, cisplatin, oral UFT, and calcium folinate in advanced gastric carcinoma.
    Kim YH; Kim BS; Seo JH; Choi CW; Kim JS; Chun HJ; Hyun JH; Kim JS
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):64-8. PubMed ID: 10442365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.
    Pyrhönen S; Valtonen M
    Lancet; 1990 Jul; 336(8707):127. PubMed ID: 1975317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.